Mark Cuban's Cost Plus Drugs often beats employer plan cost-sharing amounts

By Allison Bell

News May 27, 2026 at 04:03 PM

Share & Print

What You Need To Know

Many of the authors, including the two top-listed authors, are cancer researchers.
Some have asked whether Cost Plus is a good deal for employer plan participants.
For drugs with cost-sharing over $100, the average savings was $115.

More From HR Executive

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.